National Health Investors, Inc. (NYSE:NHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Friday.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

NHI has been the topic of a number of other research reports. BidaskClub downgraded National Health Investors from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. ValuEngine downgraded National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Stifel Nicolaus upped their target price on National Health Investors from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Wednesday, June 21st. KeyCorp reiterated a “hold” rating on shares of National Health Investors in a report on Sunday, September 17th. Finally, Mizuho reiterated a “neutral” rating on shares of National Health Investors in a report on Wednesday, June 28th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the stock. National Health Investors currently has an average rating of “Hold” and an average price target of $80.50.

Shares of National Health Investors (NYSE NHI) opened at 79.03 on Friday. The stock has a 50 day moving average price of $78.73 and a 200 day moving average price of $76.04. The firm has a market cap of $3.24 billion, a PE ratio of 20.30 and a beta of 0.56. National Health Investors has a 52 week low of $66.31 and a 52 week high of $81.29.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business had revenue of $69.84 million for the quarter, compared to analysts’ expectations of $67.68 million. During the same quarter in the prior year, the firm earned $1.22 EPS. The firm’s revenue for the quarter was up 14.1% on a year-over-year basis. Equities analysts expect that National Health Investors will post $3.85 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This story was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.thecerbatgem.com/2017/09/22/national-health-investors-inc-nhi-rating-lowered-to-hold-at-zacks-investment-research.html.

In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total value of $159,600.00. Following the transaction, the insider now directly owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 5.19% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. US Bancorp DE lifted its holdings in shares of National Health Investors by 0.5% during the 2nd quarter. US Bancorp DE now owns 8,836 shares of the real estate investment trust’s stock valued at $700,000 after buying an additional 44 shares during the period. Woodmont Investment Counsel LLC lifted its holdings in shares of National Health Investors by 1.3% during the 2nd quarter. Woodmont Investment Counsel LLC now owns 3,414 shares of the real estate investment trust’s stock valued at $270,000 after buying an additional 45 shares during the period. Teacher Retirement System of Texas lifted its holdings in shares of National Health Investors by 2.0% during the 2nd quarter. Teacher Retirement System of Texas now owns 3,192 shares of the real estate investment trust’s stock valued at $253,000 after buying an additional 62 shares during the period. QS Investors LLC lifted its holdings in shares of National Health Investors by 0.8% during the 2nd quarter. QS Investors LLC now owns 7,934 shares of the real estate investment trust’s stock valued at $628,000 after buying an additional 62 shares during the period. Finally, Family Legacy Inc. lifted its holdings in shares of National Health Investors by 0.4% during the 2nd quarter. Family Legacy Inc. now owns 17,115 shares of the real estate investment trust’s stock valued at $1,355,000 after buying an additional 65 shares during the period. 70.67% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Company Profile

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.